TR201618140A2 - Bariyer Uçlu Embolizan Ajan Teslim Sistemi - Google Patents
Bariyer Uçlu Embolizan Ajan Teslim Sistemi Download PDFInfo
- Publication number
- TR201618140A2 TR201618140A2 TR2016/18140A TR201618140A TR201618140A2 TR 201618140 A2 TR201618140 A2 TR 201618140A2 TR 2016/18140 A TR2016/18140 A TR 2016/18140A TR 201618140 A TR201618140 A TR 201618140A TR 201618140 A2 TR201618140 A2 TR 201618140A2
- Authority
- TR
- Turkey
- Prior art keywords
- tip
- catheter
- barrier
- delivery
- embolizing agent
- Prior art date
Links
- 230000004888 barrier function Effects 0.000 title claims abstract description 28
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 41
- 238000002604 ultrasonography Methods 0.000 claims abstract description 6
- 208000019553 vascular disease Diseases 0.000 claims abstract description 4
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 239000010936 titanium Substances 0.000 claims description 3
- 229910052719 titanium Inorganic materials 0.000 claims description 3
- 229910000684 Cobalt-chrome Inorganic materials 0.000 claims description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 2
- 238000002583 angiography Methods 0.000 claims description 2
- 239000010952 cobalt-chrome Substances 0.000 claims description 2
- 239000010935 stainless steel Substances 0.000 claims description 2
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims 5
- 230000001070 adhesive effect Effects 0.000 claims 5
- 206010053648 Vascular occlusion Diseases 0.000 claims 1
- 208000021331 vascular occlusion disease Diseases 0.000 claims 1
- 210000003462 vein Anatomy 0.000 abstract description 22
- 238000011282 treatment Methods 0.000 abstract description 8
- 230000005540 biological transmission Effects 0.000 abstract description 6
- 238000002347 injection Methods 0.000 abstract description 6
- 239000007924 injection Substances 0.000 abstract description 6
- 230000002792 vascular Effects 0.000 abstract description 3
- 206010046996 Varicose vein Diseases 0.000 abstract description 2
- 230000010102 embolization Effects 0.000 abstract description 2
- 208000027185 varicose disease Diseases 0.000 abstract description 2
- 229910000831 Steel Inorganic materials 0.000 abstract 1
- 210000003484 anatomy Anatomy 0.000 abstract 1
- 239000010959 steel Substances 0.000 abstract 1
- 210000001367 artery Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001736 capillary Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical compound [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2016/18140A TR201618140A2 (tr) | 2016-12-08 | 2016-12-08 | Bariyer Uçlu Embolizan Ajan Teslim Sistemi |
| PCT/TR2017/050194 WO2018106202A1 (fr) | 2016-12-08 | 2017-05-15 | Système de distribution d'agent d'embolisation à extrémité de barrière |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2016/18140A TR201618140A2 (tr) | 2016-12-08 | 2016-12-08 | Bariyer Uçlu Embolizan Ajan Teslim Sistemi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201618140A2 true TR201618140A2 (tr) | 2018-06-21 |
Family
ID=59969208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2016/18140A TR201618140A2 (tr) | 2016-12-08 | 2016-12-08 | Bariyer Uçlu Embolizan Ajan Teslim Sistemi |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR201618140A2 (fr) |
| WO (1) | WO2018106202A1 (fr) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003265898A1 (en) * | 2002-09-05 | 2004-03-29 | Genentech, Inc. | Infusion catheter having an integrated doppler transducer |
| US9375223B2 (en) * | 2009-10-06 | 2016-06-28 | Cardioprolific Inc. | Methods and devices for endovascular therapy |
| US8992513B2 (en) * | 2011-06-30 | 2015-03-31 | Angiodynamics, Inc | Endovascular plasma treatment device and method of use |
| US8702678B2 (en) * | 2011-08-03 | 2014-04-22 | Venous Therapy, Inc. | Assemblies, systems, and methods for infusing therapeutic agents into the body |
| EP2741804B1 (fr) * | 2011-08-11 | 2017-04-26 | Osprey Medical Inc. | Système et procédé de traitement des membres |
| EP2656869B1 (fr) * | 2012-04-24 | 2020-10-14 | angioclinic AG | Composition pour traiter les insuffisances veineuses et veines variqueuses |
| JP2016519588A (ja) * | 2013-03-15 | 2016-07-07 | アーセナル メディカル， インコーポレイテッド | 動脈瘤の処置のためのシステムおよび方法 |
-
2016
- 2016-12-08 TR TR2016/18140A patent/TR201618140A2/tr unknown
-
2017
- 2017-05-15 WO PCT/TR2017/050194 patent/WO2018106202A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018106202A1 (fr) | 2018-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7315915B2 (ja) | 穿刺システム | |
| US6511472B1 (en) | Interface needle and method for creating a blunt interface between delivered liquids | |
| US7163533B2 (en) | Vascular treatment device and method | |
| Molyneux et al. | Embolization of spinal cord arteriovenous malformations with an ethylene vinyl alcohol copolymer dissolved in dimethyl sulfoxide (Onyx liquid embolic system): Report of two cases | |
| Min et al. | Transcatheter duplex ultrasound-guided sclerotherapy for treatment of greater saphenous vein reflux: preliminary report | |
| Desmyttere et al. | Endovenous laser ablation (980 nm) of the small saphenous vein in a series of 147 limbs with a 3-year follow-up | |
| JP6655102B2 (ja) | エコー源性カテーテル部材 | |
| Yakes et al. | Percutaneous embolization of arteriovenous malformations at the plantar aspect of the foot | |
| JP2011506317A (ja) | 生体組織の温熱処置のためのシステム及び方法 | |
| Muto et al. | Therapeutic embolization of oral hemangiomas with absolute ethanol | |
| Walker et al. | Direct puncture of the superficial temporal artery in embolization of a scalp arteriovenous fistula: a case report | |
| Xu et al. | Clinical evaluation of covered stents in the treatment of superficial femoral artery pseudoaneurysm in drug abusers | |
| TR201618140A2 (tr) | Bariyer Uçlu Embolizan Ajan Teslim Sistemi | |
| Svendsen et al. | Direct puncture of large arteriovenous malformations in head and neck for embolisation and subsequent reconstructive surgery | |
| Burbridge et al. | Arm placement ofthe Cook titanium Petite Vital-Port: results of radiologic placement in 125 patients with cancer | |
| Reus et al. | Treatment of a radial artery pseudoaneurysm with ultrasound‐guided percutaneous thrombin injection in a patient with Behçet's syndrome | |
| EP3838194A1 (fr) | Substance thérapeutique administrée par voie percutanée pour le traitement des tissus cibles | |
| Tobis et al. | Laser-assisted versus mechanical recanalization of femoral arterial occlusions | |
| Kolvenbach et al. | The V-block occlusion stent and sclerotherapy device for varicose vein treatment: a retrospective analysis | |
| Hu et al. | Application of Delayed Surgical Managements in Patients with Stensen's duct injury | |
| Holden et al. | A First-in-Human Trial of a New Aqueous Ionic Liquid Embolic Material in Distal Embolization Applications | |
| Jeans et al. | A new technique for nonsurgical repair of peripheral pseudoaneurysm | |
| Pecis et al. | Occlusion of the great and small saphenous vein using copolymeric glue based on N-butyl cyanoacrylate and methacryloxy sulfolane | |
| Abdul Rahim et al. | Embozene Loaded Prostatic Artery Embolization. | |
| RU2535105C2 (ru) | Способ лечения ангиодисплазий |